Arrowhead Pharmaceuticals Inc. (ARWR) Reports Q2 EPS of $0.45
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $66.48 -1.86%
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of $0.45, versus $0.41 reported last year. Revenue for the quarter came in at $146.3 million, versus $151.8 million reported last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold
- Arrive AI and DXC Technology partner to bring delivery tech to factories
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
